Chase, Dana M.
Mahajan, Anadi
Scott, David Alexander
Hawkins, Neil
Kalilani, Linda
Funding for this research was provided by:
GSK (OneCDP 214515, OneCDP 214515, OneCDP 214515, OneCDP 214515, OneCDP 214515)
Article History
Received: 1 November 2023
Accepted: 17 February 2024
First Online: 15 March 2024
Declarations
:
: Not applicable.
: Not applicable.
: DC reports speakers’ bureau fees and/or advisory roles from GSK, AstraZeneca, Takeda, Clovis, Roche, and Merck. AM, DAS, and NH have no conflict of interest to disclose. LK is an employee of GSK.